Global Biopharmaceutical Contract Manufacturing Industry Soaring to US$ 18.7 Billion by 2029, Driven by an Impressive CAGR of 10.5% | FMI
Global Biopharmaceutical Contract Manufacturing Industry was estimated to be worth roughly US$ 9.3 Billion in 2022 and is expected